ABPI Insider Trading Activity and SEC Form 4 Filings
ABPI insider trading summary
No open-market insider purchases or sales of Accentia Biopharmaceuticals Inc (ABPI) have been reported on SEC Form 4 in the past 12 months.
Latest ABPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 23, 2011 | Francis E Odonnell Jr | Executive Chairman | Sell | $100K (500,000 @ $0.20) |
| Nov 24, 2010 | Francis E Odonnell Jr | Chairman & CEO | Buy | $224K (225,954 @ $0.99) |
| Aug 12, 2008 | Francis E Odonnell Jr | Chief Executive Officer | Buy | $11K (11,400 @ $0.95) |
| Aug 11, 2008 | Francis E Odonnell Jr | Chief Executive Officer | Buy | $13K (13,600 @ $0.94) |
| Aug 8, 2008 | Francis E Odonnell Jr | Chief Executive Officer | Buy | $23K (25,000 @ $0.94) |
| Aug 6, 2008 | Francis E Odonnell Jr | Chief Executive Officer | Buy | $21K (25,000 @ $0.84) |
| Aug 5, 2008 | Francis E Odonnell Jr | Chief Executive Officer | Buy | $20K (25,000 @ $0.79) |
| Aug 4, 2008 | Francis E Odonnell Jr | Chief Executive Officer | Buy | $20K (25,000 @ $0.79) |
| Aug 1, 2008 | Francis E Odonnell Jr | Chief Executive Officer | Buy | $21K (25,000 @ $0.84) |
| Jul 31, 2008 | Francis E Odonnell Jr | Chief Executive Officer | Buy | $22K (25,000 @ $0.86) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.